Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.1.7 (
acetylcholinesterase
)
28,390
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cholinesterase activity of brain and content of growth hormone and
prolactin
in the pituitary were compared after short-term (3 days) and long-term (14 days) treatment with paraoxon in male and female rats. Within 3 days
cholinesterase
activity was reduced to between 5 and 15 percent of that in controls. The content of growth hormone in the pituitary was increased in long-term experiments by 50 percent. This increase in paraoxon-treated animals-suggests a possible role of a cholinergic mechanism in the regulation of growth hormone secretion.
...
PMID:Paraoxon: effects on rat brain cholinesterase and on growth hormone and prolactin of pituitary. 506 Dec 47
The space adaptation syndrome is one of the more vexing problems confronted by our nation's astronauts during their journeys. This syndrome may be a variant of motion sickness, although this possibility has been questioned. Physostigmine, a centrally active
cholinesterase
inhibitor which increases brain acetylcholine, was found to cause a motion sickness-like syndrome--in psychiatric patients and normals--including nausea, emesis, malaise, dysphoria, increases in serum ACTH, beta-endorphin, cortisol, and
prolactin
, Neostigmine, a non-centrally acting
cholinesterase
inhibitor, and saline placebo caused no such effects. The above effects closely parallel those of motion sickness. Thus, the effects of physostigmine may be a convenient model for screening for treatments for motion sickness or space adaptation syndrome, or for predicting who will develop these syndromes.
...
PMID:A cholinomimetic model of motion sickness and space adaptation syndrome. 648 3
Consumption of ethanol by rats during pregnancy reduces the body and brain weight of their fetuses and pups. The reduction is greater if the offspring are kept with their alcohol-fed mothers rather than with control surrogate mothers during lactation. The activity of several enzymes of the neuronal cell membranes (Na+, K+-ATPase, Ca2+-ATPase,
acetylcholinesterase
, 5'-nucleotidase) is also reduced. This decrease in enzyme activity may be related to the decrease in neuronal development and could produce profound alterations in brain function. Altered hypothalamic-hypophysial function may be partly responsible for developmental anomalies found in the fetal alcohol syndrome. The levels of plasma luteinizing hormone are lower in pups exposed prenatally to ethanol, and
prolactin
levels are much higher. Concentrations of ethanol were essentially the same in maternal blood and in the fetus. Acetaldehyde levels in the placenta, amniotic fluid and the remaining fetal tissue at days 15 and 19 of gestation were about 40-50% of those in maternal blood. Acetaldehyde may be important in the pathogenesis of the fetal alcohol syndrome.
...
PMID:Growth, enzymes and hormonal changes in offspring of alcohol-fed rats. 656 94
The effect of a single dose (15 g/70 kg) of lecithin (95% phosphatidylcholine) on several measures of central cholinergic activity (memory, cortisol,
prolactin
, pulse, blood pressure) was assessed in individuals with Alzheimer's disease. In contrast to the reported effects of physostigmine, a
cholinesterase
inhibitor, lecithin had no effect on these parameters, despite significant increases in plasma and erythrocyte choline.
...
PMID:Failure of single-dose lecithin to alter aspects of central cholinergic activity in Alzheimer's disease. 687 50
Chronic oral administration of ammonium molybdate in rats markedly retarded the growth rate of rats and high protein diet could partially reverse this condition. The activities of several enzymes viz. acid phosphatase, alkaline phosphatase, glucose-6-phosphatase, succinic dehydrogenase, glutamate oxaloacetate transaminase, inorganic pyrophosphatase and
acetylcholinesterase
in different tissues and serum levels of luteinizing hormone, follicle stimulating hormone,
prolactin
and cortisol are altered due to the toxicity conditions and high protein diet fed group of animals showed almost normal values in respect of a few of these parameters. Normal histological pattern of both liver and kidney tissues were altered under molybdenum toxicity condition. Significant increase of basophilic substances are observed in the cytoplasm of the liver cells of the toxic group of animals which is counteracted by feeding high protein diet.
...
PMID:Biochemical studies on molybdenum toxicity in rats: effects of high protein feeding. 732 62
Endogenous cholinergic stimulation, produced by the intravenous injection of edrophonium (10 mg), an
acetylcholinesterase
inhibitor, into 8 normal human subjects, resulted in an increase in the mean (+/- SE) serum growth hormone (GH) concentration from 0.6 +/- 0.1 ng/ml to 5.6 +/- 1.4 ng/ml (p < 0.01) at 40 min with no changes in serum
prolactin
. In 2 subjects sampled for 140 min. maximum serum GH levels of 19.4 and 10.2 ng/ml (from baseline values of 0.4 and 0.6 ng/ml) occurred at 65 min after edrophonium injection. Thus, enhancement of endogenous cholinergic activity stimulates GH secretion, providing further evidence for a role of cholinergic mechanisms in the physiologic regulation of GH secretion in man. The theoretical possibility that excessive endogenous cholinergic activity might be involved in the pathophysiologic regulation of GH secretion in man. The theoretical possibility that excessive endogenous cholinergic activity might be involved in the pathophysiologic regulation of GH secretion in acromegaly was not, however, supported, since methscopolamine (0.5 mg s.c.), a cholinergic antagonist, did not reduce mean serum GH levels in 3 acromegalic patients.
...
PMID:Endogenous cholinergic modulation of growth-hormone secretion in normal and acromegalic humans. 740 75
Pyridostigmine (PST), a
cholinesterase
inhibitor, induces a clear growth hormone (GH) release in man by suppression of hypothalamic somatostatin (SRIH). Somatostatin suppresses thyrotrophin (TSH) release in rats and men. Earlier studies showed that the thryotrophin-releasing hormone (TRH)-induced TSH response was not altered by 60-120 mg of PST. We studied whether a larger dose (180 mg) of PST can increase the TSH response to TRH. Six healthy young men were studied with the following six tests: (Test 1) 200 micrograms of TRH i.v.; (Test 2) 180 mg of PST po; (Test 3) three different doses of PST (60, 120, 180 mg) + TRH; (Test 4) 100 micrograms of octreotide (SMS) i.v.; (Test 5) SMS + TRH; (Test 6) PST + SMS + TRH. A large dose of PST (180 mg) significantly augmented GH, TSH and
prolactin
responses to TRH, while smaller doses of PST (60 and 120 mg) did not significantly increase the responses of GH and TSH. While the increased TRH-induced
prolactin
response by PST was not suppressed by SMS, the increased responses of GH and TSH were suppressed remarkably by SMS. Most of the subjects noticed a mild to moderate abdominal pain, nausea and muscular fasciculation after the administration of a large dose of PST administration. These data suggest that suppression of hypothalamic SRIH secretion by 180 mg of PST can augment the TSH response to TRH. However, the considerable side effects should be minimized before clinical application of the combined PST-TRH test.
...
PMID:Combined pyridostigmine-thyrotrophin-releasing hormone test for the evaluation of hypothalamic somatostatinergic activity in healthy normal men. 758 70
The response to acetylcholine (ACh) can be used as a marker for larval-type bullfrog skin because apically applied ACh induces an increase in short-circuit current (SCC) in larval-type but not adult-type skin. EDTA-treated larval skin, which contains only basal cells and does not respond to ACh, was used as the starting material for our culture. ACh, carbamylcholine, and choline stimulated SCC in skin that had been cultured with aldosterone (5 x 10(-7) M) supplemented with
prolactin
(PRL; 2 micrograms/ml). Atropine and d-tubocurarine each inhibited the ACh-induced stimulation of SCC in skin so cultured. Eserine, an inhibitor of
acetylcholinesterase
, also inhibited the ACh response. Amiloride stimulated SCC itself, but it reduced the ACh response. All of these results are quite similar to those seen in intact larval skin, suggesting that a larval-skin had differentiated from the basal cells used as the starting point for our culture. This is the first physiological report that PRL induces differentiation in vitro into a true larval-type bullfrog skin.
...
PMID:Prolactin enables normal development of ACh-stimulated current in cultured larval bullfrog skin. 889 10
In critical illness, several drugs and various stressful conditions modify the functions of neurotransmitters which consequently affect the secretion of pituitary hormones. Although the role of neurotransmitters in the regulation of endocrine system is well known, cholinergic actions have been less investigated. In animals,
cholinesterase
inhibitors were shown to modify the pituitary-thyroid and pituitary-adrenal axes, and to affect
prolactin
levels. The aim of the present study was to determine the effect of the organophosphate compounds on endocrine system, particularly pituitary hormones. This prospective study was performed in Medical Intensive Care Unit of Erciyes University Medical School Hospital. Twenty-two consecutive patients (ten males and 12 females aged 28+/-8 years) with organophosphate poisoning were included in the study. ACTH (P<0.002), cortisol (P<0.0005) and PRL (P<0.005) levels were significantly higher during poisoning than after resolution of poisoning. FSH levels were significantly lower during poisoning (P<0. 05). Sick euthyroid syndrome was determined in seven patients (31. 8%). Two of them had low fT3 (with normal fT4 and TSH), two had low fT4 (with normal fT3 and TSH) and three had low TSH (with normal fT3 and fT4) levels. Serum levels of these hormones returned to normal values after resolution of poisoning. The present study demonstrated that organophosphate compounds affected PRL, ACTH and cortisol levels, but did not change LH levels. Organophosphate compounds may result in sick euthyroid syndrome. These conditions may be related to the effects of acetylcholine and direct effect of organophosphate compounds.
...
PMID:Endocrine changes in patients with acute organophosphate poisoning. 1055 9
The effects of chronic sub-lethal doses (7-14 mg kg-1 a day for 15 days) of quinalphos were evaluated in adult male rats for changes in testicular morphology, circulatory concentrations of hormones (LH, FSH,
prolactin
and testosterone), activities of
acetylcholinesterase
(
AChE
) and angiotensin converting enzyme (ACE) as well as metabolism of biogenic amines (dopamine, noradrenaline and 5-hydroxytryptamine (5-HT)) in the hypothalamus and pituitary. Hormones were assayed by radioimmunoassay or chemiluminescent immunoassay (testosterone). The enzymes were estimated after spectrophotometry and the biogenic amines by HPLC-electrochemistry. Sub-lethal chronic administration of quinalphos resulted in: decreased testicular mass and
AChE
activity in central as well as peripheral organs; increased serum LH, FSH,
prolactin
and testosterone concentrations; decreased pituitary or increased testicular ACE activity; severe disruption of spermatogenesis with increasing doses of pesticide; and no significant effects on dopamine, noradrenaline or 5-HT concentrations in the hypothalamus or pituitary. Administration of oestradiol (50 micrograms per rat a day) during pesticide treatment resulted in: a significant decrease in the mass of the testis and accessory sex organs; decreases in serum LH, FSH, testosterone concentrations; an increase in
prolactin
concentration; and a decrease in dopamine or an increase in noradrenaline and 5-HT in the hypothalamus or pituitary. Oestradiol had a marked effect: in pesticide-treated animals, the pesticide effects were significantly reversed. This indicates that in pesticide toxicity, the hypothalamo-pituitary-gonadal axis is operational. Since many of the observed pesticide effects could be inhibited by oestradiol, it is suggested that the pesticide acts directly on the gonadotrophins. In conclusion, quinalphos decreases fertility in adult male rats by affecting the pituitary gonadotrophins.
...
PMID:Effects of an organophosphate pesticide, quinalphos, on the hypothalamo-pituitary-gonadal axis in adult male rats. 1079 23
<< Previous
1
2
3
Next >>